Compare ACNT & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACNT | INFU |
|---|---|---|
| Founded | 1945 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.7M | 182.4M |
| IPO Year | N/A | N/A |
| Metric | ACNT | INFU |
|---|---|---|
| Price | $17.20 | $7.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 62.1K | ★ 144.5K |
| Earning Date | 03-03-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 271.43 |
| EPS | 0.09 | ★ 0.26 |
| Revenue | ★ $171,413,000.00 | $141,054,000.00 |
| Revenue This Year | $22.72 | $8.82 |
| Revenue Next Year | N/A | $2.90 |
| P/E Ratio | $183.54 | ★ $29.76 |
| Revenue Growth | ★ 65.05 | 6.23 |
| 52 Week Low | $10.96 | $4.61 |
| 52 Week High | $17.29 | $11.04 |
| Indicator | ACNT | INFU |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 31.42 |
| Support Level | N/A | $7.51 |
| Resistance Level | N/A | $8.47 |
| Average True Range (ATR) | 0.00 | 0.38 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 0.00 | 2.07 |
Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.